What Are the Symptoms of Hepatitis B? Diagnosis and Treatment Process

Fatigue, loss of appetite, nausea, abdominal pain, dark urine, and jaundice are among the symptoms of hepatitis B, but the infection can also be detected in people who have no symptoms at all. Diagnosis relies on tests such as HBsAg, anti-HBs, anti-HBc, and, when necessary, HBV DNA. The monitoring and treatment approach for acute and chronic infection differs.

Hepatitis B is a viral disease that affects the liver and can be short-lived in some people while becoming a chronic infection in others. Hepatitis B symptoms do not appear the same way in every patient; in fact, the infection can progress for a long time without any symptoms. For this reason, diagnosis is based not only on complaints but also on blood tests and liver evaluation. The treatment plan is determined according to the duration of the infection and the condition of the liver.

What Is Hepatitis B?

Hepatitis B is a contagious infection in which the hepatitis B virus (HBV) affects liver cells. It can follow a short-term (acute) course or remain in the body for a long time (chronic). Because it affects the liver, it can lead to serious health problems over time.

How Is Hepatitis B Transmitted?

HBV is transmitted when the blood and certain body fluids (especially semen and vaginal fluid) of an infected person come into contact with the bloodstream or mucosal surfaces of an uninfected person. The most common routes of transmission are unprotected sexual contact, sharing needles or syringes, unsterile tattoo and piercing procedures, sharing sharp personal items that have come into contact with blood such as razors and manicure-pedicure tools, and transmission from mother to baby during birth. Occupational exposures such as needlestick injuries also pose a risk for healthcare workers.

The virus is not transmitted by hugging, coughing, sneezing, eating from the same plate, through water or air, or through everyday social contact.

Differences Between Acute and Chronic Hepatitis B

Acute hepatitis B refers to the first six-month period following exposure to the virus. While the majority of infections acquired in adulthood are cleared by the immune system, the likelihood of becoming chronic is significantly higher in infections acquired during infancy and early childhood. In the acute period, fever, weakness, nausea, or jaundice may occur, or there may be no symptoms at all.

Chronic hepatitis B is assessed when HBsAg positivity persists for longer than six months and requires long-term monitoring. During this period, a person may feel completely healthy while the virus remains active in the liver or becomes reactivated over time. For this reason, in chronic infection not only hepatitis B symptoms but also HBV DNA level, liver enzymes, fibrosis status, and other clinical findings are considered together.

What Are the Symptoms of Hepatitis B?

Hepatitis B symptoms can vary depending on the stage of infection, the person’s age, and immune response. In the acute period, findings such as fatigue, fever, loss of appetite, nausea, vomiting, abdominal pain, and jaundice may be seen. Chronic infection, on the other hand, can remain silent for a long time, and the absence of symptoms does not mean the liver is unaffected. The severity of symptoms can vary from person to person.

Early Symptoms of Hepatitis B

Hepatitis B infection does not always begin with obvious and easily noticeable complaints. In some people the disease progresses silently for a long time, while in others it may present with mild flu-like complaints. For this reason, knowing the symptoms that may appear in the early period is important both for speeding up the diagnostic process and for getting tested at the right time after a possible risky exposure.

Early symptoms of hepatitis B:

• Weakness
• Mild fever
• Loss of appetite
• Nausea
• Vomiting
• Muscle aches
• Joint pain
• Headache
• Mild abdominal discomfort
• General feeling of malaise
• Dark-colored urine
• Light-colored stool
• Yellowing of the whites of the eyes
• Yellowing of the skin (jaundice)
• Tenderness in the liver area
• Most symptoms follow a flu-like course
• Can progress without symptoms in the early period
• Testing is required after risky exposure
• Development of jaundice generally indicates a more advanced stage

If you notice one or more of these symptoms, especially if you have a history of risky exposure, it is important to consult a healthcare facility without delay and have the necessary tests done.

Symptoms That May Appear in the Advanced Stage

When chronic hepatitis B infection progresses and causes serious liver damage, particularly cirrhosis or liver failure, more pronounced and severe findings affecting different systems of the body may occur. These symptoms generally point to advanced stages of the disease and indicate that the liver is not performing its functions adequately.

Advanced-stage symptoms of hepatitis B:

• Noticeable swelling due to fluid buildup in the abdomen (ascites)
• Swelling in the legs and ankles
• Tendency toward easy bruising and bleeding in the skin and gums
• Pronounced and persistent feeling of weakness and fatigue
• Severe itching
• Involuntary weight loss along with loss of appetite
• Mental confusion, drowsiness, and changes in consciousness (hepatic encephalopathy)
• More pronounced yellowing of the whites of the eyes and skin
• In advanced cases, bloody vomiting or black-colored stools (signs of variceal bleeding)

If you notice these symptoms, medical evaluation should be sought without delay.

Can Hepatitis B Occur Without Symptoms?

In both acute and chronic infection, a person can carry HBV without experiencing any symptoms. The CDC reports that a significant portion of acute infections are asymptomatic, while it emphasizes that in many people with chronic infection, complaints may not appear for years or even decades. For this reason, the absence of hepatitis B symptoms does not mean there is no infection.

In particular, testing needs are assessed independently of symptoms for people who live in the same household as someone who is HBV positive, people who have sexual contact with an infected person, people with a risk of blood contact, pregnant women, and people with other risk factors.

How Is Hepatitis B Diagnosed?

A diagnosis of hepatitis B cannot be confirmed by looking at physical symptoms alone; laboratory tests are required. Serological tests help distinguish whether a person has an active infection, has had an infection in the past, or has gained immunity through vaccination.

HBsAg and Other Blood Tests

Blood tests used in the diagnosis of hepatitis B play an important role in understanding the presence of the infection, its stage, and the person’s immune status. These tests are not interpreted individually but are evaluated together.

HBsAg (Hepatitis B surface antigen):

• A positive result indicates an active HBV infection in the body.
• It is evaluated together with additional tests to determine whether the infection is acute or chronic.

Anti-HBs (Hepatitis B surface antibody):

• A negative result indicates recovery after infection or immunity developed through vaccination.
• A positive result indicates that the person has gained protective immunity against hepatitis B.

Total Anti-HBc (Hepatitis B core antibody):

• Indicates that the person has encountered the virus at some point in their life.
• It is an important marker in distinguishing between active infection and past infection.

IgM Anti-HBc:

• Used especially when acute infection is suspected.
• A positive result is consistent with a recently acquired infection.

Duration of HBsAg:

• HBsAg remaining positive for longer than six months is assessed in terms of chronic hepatitis B infection.

Since different combinations of these tests carry different clinical meanings, it is not correct to interpret a single result on its own. Diagnosis and evaluation must always be made by a physician, taking all tests into account together.

Liver Function Tests

ALT (Alanine aminotransferase) and AST (Aspartate aminotransferase): These are the most basic enzymes indicating liver cell damage. Elevated levels suggest that there may be inflammation or damage in the liver.

Bilirubin: Indicates the liver’s capacity to process waste products. Elevated levels may be associated with jaundice.

Albumin: Assesses the liver’s protein production capacity. Low levels may indicate impairment of liver function.

Coagulation tests (INR, PT): Indicate the liver’s ability to produce the proteins needed for blood clotting.

Changes in liver enzymes are evaluated together with HBV DNA and fibrosis findings when deciding whether antiviral treatment is necessary. Because a single elevated ALT value can also occur for other reasons, the trend over time is important. The physician also comprehensively evaluates medications used, alcohol consumption, accompanying infections, and metabolic diseases.

HBV DNA and Imaging Methods

Evaluation of hepatitis B infection uses not only blood tests but also various diagnostic methods that show the activity of the virus and the structural changes it causes in the liver. These methods play an important role both in determining the stage of the disease and in monitoring the response to treatment. Regular follow-up is particularly important for detecting liver damage at an early stage in chronic infection.

The main methods used to evaluate hepatitis B are:

• HBV DNA test (viral load measurement): Numerically shows the amount of virus present in the blood. It is one of the most important tests for understanding whether the virus is actively replicating. A high HBV DNA level may indicate that the infection is more active and that the risk of liver damage may increase. Whether treatment should be started and the evaluation of treatment response are closely related to this test.
• Liver function tests (ALT, AST, etc.): Show whether there is damage to liver cells. An increase in these enzymes suggests inflammation in the liver. However, a normal result does not always mean the disease is absent; therefore it is evaluated together with other tests.
• Ultrasonography (US): Used to assess the general structure and size of the liver and possible changes such as masses or fatty infiltration. It is a painless and easily applicable imaging method. It is routinely preferred for the long-term follow-up of the liver in chronic hepatitis B patients.
• Elastography (FibroScan): Provides information about the level of fibrosis (scar tissue) by measuring the stiffness of the liver. This needle-free method is frequently used as an alternative to liver biopsy. It is particularly valuable in assessing the risk of developing cirrhosis.
• Magnetic Resonance Imaging (MRI) and Computed Tomography (CT): Used when more detailed imaging is required. They may be preferred in cases such as suspected liver mass, cirrhosis complications, or cancer screening. They provide additional evaluation especially in advanced-stage patients.
• Liver biopsy: The process of taking a small sample of liver tissue and examining it microscopically. Although it is used less frequently today, it is still considered the gold standard method for definitively determining the stage of the disease in certain situations.
• Hepatocellular carcinoma (liver cancer) screening methods: In chronic hepatitis B patients at risk, cancer screening can be performed with regular ultrasound and alpha-fetoprotein (AFP) testing. This follow-up is vital for early diagnosis.

Which of these methods will be used is determined based on the patient’s age, HBV DNA level, liver enzymes, presence of cirrhosis, family history, and overall risk profile. Through regular follow-up, disease progression can be detected early and an appropriate treatment plan can be developed.

How Is Hepatitis B Treated?

The treatment approach differs between acute and chronic infection. Acute cases are generally monitored with supportive treatment, and severe cases may be followed up in hospital. In chronic infection, the need for medication is determined according to the stage of the disease and clinical findings; in suitable patients, antiviral treatment aims to slow disease progression.

Acute Hepatitis B Treatment

In most patients, the approach to acute infection is supportive; according to current WHO and CDC information, there is no specific medication routinely used to eliminate the virus. In mild cases, adequate fluid intake, balanced nutrition, and clinical monitoring are the main focus. Hospital follow-up may be required if fluid loss due to vomiting, severe jaundice, or signs of liver failure develop.

During this period, it is important not to use medications or herbal products without a doctor’s recommendation; some substances can place additional strain on the liver. Avoiding alcohol consumption and not skipping follow-up tests is necessary. There is no fixed timetable for the duration of hepatitis B treatment in acute infection that applies to everyone; the process is monitored based on clinical improvement and laboratory evidence of whether the virus has been cleared.

Chronic Hepatitis B Treatment

Chronic hepatitis B treatment aims to suppress the virus and prevent the progression of liver damage. The World Health Organization states that oral antivirals such as tenofovir or entecavir can be used in chronic infection. The decision to start medication is made not only based on HBsAg positivity, but by evaluating HBV DNA, ALT, the presence of fibrosis or cirrhosis, and other patient-specific risks together.

Although antiviral drugs can strongly suppress the virus, in most patients they do not provide a cure that completely eliminates the infection. For this reason, the duration of hepatitis B treatment in chronic infection is generally long, and in some people treatment may need to continue for years or even for life. The decision of whether the medication can be discontinued should not be made by the patient alone but by the physician, who evaluates specific clinical and virological criteria.

The Importance of Treatment and Regular Follow-up

Regular follow-up is necessary to assess, in people receiving hepatitis B treatment, how well the medication is suppressing the virus, the course of liver enzymes, and possible side effects. Follow-up does not end for chronic HBV patients who are not on medication either; viral activity and liver damage can change over time. The frequency of check-ups is planned according to the stage of the disease, the treatment used, and personal risks.

During follow-up, in addition to HBV DNA, ALT, and other blood tests, fibrosis assessment or imaging may be requested. Regular check-ups can help identify adverse changes before hepatitis B symptoms develop. For this reason, hepatitis B treatment is not limited to medication use alone; it is a process that includes long-term clinical monitoring, protection of liver health, and management of the risk of complications.

What Are the Ways to Prevent Hepatitis B?

Vaccination is the primary measure for preventing hepatitis B. In addition, it is important to take necessary precautions against situations where the virus can be transmitted through blood and body fluids, to reduce risky contact, and to avoid sharing personal items.

Hepatitis B Vaccine

The hepatitis B vaccine is the primary method of prevention against HBV infection. The World Health Organization recommends that all infants receive the first dose, if possible, within 24 hours of birth, and that the vaccination series be completed. The vaccination schedule should be determined by a healthcare professional according to age and health status.

The vaccine is used not to treat infection but to build immunity before encountering the virus. Serological tests can be a helpful guide for people who do not know whether they have been vaccinated before or who are in a risk group. It is especially important to assess the immune status of people who live in the same household as someone carrying HBV and of sexual partners.

Ways to Reduce the Risk of Transmission

Not sharing personal items that may come into contact with blood, using single-use or properly sterilized needles and equipment, following infection control rules during medical procedures, and using protective measures during sexual contact all reduce the risk of transmission. People carrying HBV should cover open wounds and be careful to properly clean surfaces contaminated with blood.

The Hepatitis B Treatment Process with QBA Medi Tours

QBA Medi Tours coordinates the process, from the application stage onward, for patients who want to evaluate healthcare options in Cuba. The main stages of this process include forwarding medical documents to the relevant healthcare teams, conveying the expert opinions received to the patient, and planning the organization of travel and treatment according to suitability.

Evaluation of Medical Reports

In the process, test results, imaging, and physician reports showing the patient’s current diagnosis, treatments used, and general health status are collected first. QBA Medi Tours coordinates the forwarding of these documents to the relevant healthcare institutions and specialists in Cuba, facilitating the medical evaluation of the patient’s condition.

Consultation on Treatment Options in Cuba

Following the medical evaluation, information is shared about the options that may be suitable for the patient and the process that can be followed. QBA Medi Tours provides consultancy in conveying the assessments from the healthcare teams in Cuba to the patient and in moving forward the organizational aspects of the plan in an understandable way.

Patient Coordination During the Treatment Process

If it is decided to proceed with a healthcare program in Cuba, the planning of needs such as flights, accommodation, transfers, and interpretation services is also included in the process. QBA Medi Tours supports the coordination of communication and organization between the patient and the healthcare team in Cuba, aiming for the medical planning and travel process to proceed in a coordinated manner.

You can contact QBA Medi Tours to get detailed information and start the free preliminary evaluation process.

Frequently Asked Questions

Does hepatitis B resolve on its own?

The majority of acute hepatitis B cases acquired in adulthood can be cleared by the immune system. However, if the virus remains in the body for longer than six months, chronic infection may be present and regular follow-up is needed. The risk of becoming chronic is higher particularly in infections acquired during infancy and early childhood.

What should be done if a hepatitis B test comes back positive?

It should first be determined which test the positive result belongs to; HBsAg, anti-HBs, and anti-HBc results do not mean the same thing. When active infection is detected, an evaluation in infectious diseases or gastroenterology/hepatology can be carried out, examining HBV DNA, liver enzymes, and liver damage. Whether hepatitis B treatment is needed is decided following this comprehensive evaluation.

When do hepatitis B symptoms appear?

If hepatitis B symptoms occur in acute infection, they usually begin weeks or months after exposure to the virus; the CDC reports that symptoms are often seen approximately 90 days after exposure. However, some people may not develop any symptoms at all. For this reason, the timing of testing after risky exposure should not be determined solely based on whether complaints have started.

Does chronic hepatitis B fully heal?

The antivirals used today can suppress viral replication in chronic infection and reduce the risk of serious liver disease, but in most patients they do not provide a cure that completely eliminates the infection.

Which tests are used to understand hepatitis B?

In the basic evaluation, HBsAg, anti-HBs, and total anti-HBc tests are used; IgM anti-HBc may be added when acute infection is suspected. When active infection is detected, HBV DNA helps assess viral replication. ALT, AST, and other liver tests, along with ultrasound or elastography, can also be used to assess the effect of the disease on the liver.

How long does hepatitis B treatment take?

In acute infection, the duration of hepatitis B treatment varies according to supportive care and clinical improvement; specific antiviral treatment is not applied in most cases. In chronic infection, however, treatment can be much longer, and in some patients who start antivirals it may continue for years or for life. Discontinuation of treatment should only be decided by a physician, taking into account clinical, virological, and liver-related criteria together.